Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Tuesday before market ...

Competitive dynamics loom large. Quest Diagnostics recently delivered 7.1% year-over-year revenue growth, beating estimates by 1.9%, with shares rallying 9.4% following results. That strong showing ...

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

Labcorp continues its Northeast push through a multi-year partnership with SOMOS, one of New York's largest independent ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test ...

LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions ...

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

Labcorp has been acquiring outreach lab businesses from major health systems across the country. Empire City Laboratories marks its latest move.

ACA enrollment is over, but HCSMs provide vital year-round safety nets. Christian Care Health offers netWell™ as a top ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Add Bedford and Burlington to the growing list of towns and cities across the commonwealth being hit by large layoffs in the ...